Whole-Body CT Scans, Cancer Screening Enjoy Positive Public Image – JAMA
This article was originally published in The Gray Sheet
Executive Summary
The U.S. public's apparent zeal for early cancer screening tests such as whole-body CT scans should be tempered with an understanding of the "risk for overtesting and overtreatment," the authors of a study in the Jan. 7 Journal of the American Medical Association conclude
You may also be interested in...
CT Improves Blood Clot Detection, But Whole-Body Method Likely Too Costly
Computed tomography scans of the legs can increase detection of thromboembolic disease by 20% when used in conjunction with CT pulmonary angiography, according to a study by Matthew Cham, MD, University of Rochester, N.Y., et al.
CT Improves Blood Clot Detection, But Whole-Body Method Likely Too Costly
Computed tomography scans of the legs can increase detection of thromboembolic disease by 20% when used in conjunction with CT pulmonary angiography, according to a study by Matthew Cham, MD, University of Rochester, N.Y., et al.
FDA In Brief
Clinical literature guidance: FDA is considering a collaboration with the National Institutes of Health and the Centers for Medicare & Medicaid Services on a guidance aimed at the use of literature to support claims. The device center and industry had been working on a genetic testing guidance addressing the use of literature in lieu of prospective trials (1"The Gray Sheet" Sept. 3, 2001, p. 8). That effort is currently "stalled," according to CDRH Division of Clinical Laboratory Devices Director Steven Gutman, who notes, however, that it could be revived via HHS intra-departmental collaboration. "NIH is interested in looking at use of clinical literature, and CMS is interested in looking at clinical literature. We are being instructed by [HHS Secretary] Tommy Thompson to behave as one department and try and actually be consistent across agencies," the DCLD director reports at the Association of Medical Diagnostics Manufacturers annual meeting...